Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of ciprofloxacin for treating plague in humans has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plague

Drugs mentioned

• Ciprofloxacin (Ciprofloxacin hydrochloride)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Plague | Phase 2 | Status: COMPLETED